Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis
Liangliang Dong, Shen Lin, Lixian Zhong, Dongni Nian, Yiyuan Li, Rixiong Wang, Wei Zhou, Xiuhua Weng, Xiongwei Xu
Topics & Concepts
MedicineBreast cancerOncologyInternal medicineGynecologyCancerBrain Metastases and TreatmentHER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations